Deadly Hazard Without Risk? How Toxic Exposure Has Been Downplayed in Transnational Conflicts Over Carcinogen Assessment

In contemporary carcinogen identification systems, a key distinction is made between “hazard”– the inherent potential of an exposure to cause cancer – and “risk” – the probability of cancerarising from that exposure. Drawing on an unpublished set of archives from the InternationalAgency for Research on Cancer, this article traces the origins of this distinction. Contrary to theprevailing institutional narrative, the distinction emerges not from a straightforward scientificor regulatory consensus, but from a complex jurisdictional struggle among expert groups, eachseeking to define and prioritize different methods of assessing carcinogens. Bringing togethera range of actors from scientific, economic, and regulatory spheres, this distinction has enabledsome stakeholders to challenge expert assessments and delay political decision-making.

Publication Details

Journal
Comparativ
Published
2025-10-22
DOI
https://doi.org/10.26014/j.comp.2025.03.05
Primary Topic
Environmental Justice and Health Disparities
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Deadly Hazard Without Risk? How Toxic Exposure Has Been Downplayed in Transnational Conflicts Over Carcinogen Assessment

Comparativ
Environmental Justice and Health Disparities
article

Deadly Hazard Without Risk? How Toxic Exposure Has Been Downplayed in Transnational Conflicts Over Carcinogen Assessment

article en

Abstract

In contemporary carcinogen identification systems, a key distinction is made between “hazard”– the inherent potential of an exposure to cause cancer – and “risk” – the probability of cancerarising from that exposure. Drawing on an unpublished set of archives from the InternationalAgency for Research on Cancer, this article traces the origins of this distinction. Contrary to theprevailing institutional narrative, the distinction emerges not from a straightforward scientificor regulatory consensus, but from a complex jurisdictional struggle among expert groups, eachseeking to define and prioritize different methods of assessing carcinogens. Bringing togethera range of actors from scientific, economic, and regulatory spheres, this distinction has enabledsome stakeholders to challenge expert assessments and delay political decision-making.

ComparativVol. 35(3)
Peace, Justice and strong institutions
Openalex Percentile: Top 25%
Environmental Justice and Health Disparities
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.